Related content

Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia

By  

ACTA PSYCHIATRICA SCANDINAVICA, Vol. 137, Iss. 3, 2018-03 ,pp. : 187-205

John Wiley & Sons Inc

Access to resources Recommend Favorite

Healthcare resource utilization, adherence and persistence with antipsychotic therapy among schizophrenia patients with vs. without pre-existing metabolic syndrome

By Shi Lizheng   Zhao Yingnan   Fonseca Vivian   Ascher-Svanum Haya   Chiang Yi-Ju   Winstead Daniel  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2499-2506

Informa Healthcare

Access to resources Recommend Favorite

Level of plasma thioredoxin in male patients with manic episode at initial and post‐electroconvulsive or antipsychotic treatment

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 6, 2015-06 ,pp. : 344-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors affecting the efficacy of starting insulin treatment in Type 2 diabetic patients

By Vähätalo Markku   Rönnemaa Tapani   Viikari Jorma  

Scandinavian Journal of Primary Health Care, Vol. 21, Iss. 4, 2003-12 ,pp. : 230-236

Informa Healthcare

Access to resources Recommend Favorite

The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly

By  

Current Drug Safety, Vol. 1, Iss. 3, 2006-08 ,pp. : 227-241

Bentham Science Publishers

Access to resources Recommend Favorite